School of Medicine
Showing 201-220 of 276 Results
-
Kimberly Horstman
Clinical Associate Professor, Pediatrics
BioI came late to medicine, entering medical school after a career editing children's educational books. After graduating from USC Keck School of Medicine and completing my residency at Children's Hospital Los Angeles, I worked briefly in the outpatient setting, and then started my career as a Pediatric Hospitalist in 2006. Since 2016, I have functioned primarily as a Neonatal Hospitalist at John Muir Medical Center in Walnut Creek, CA, taking care of well newborns and Level 2 and 3 NICU patients, as well as attending deliveries and performing newborn procedures.
-
Machiko Hosoki
Clinical Assistant Professor, Pediatrics
Current Research and Scholarly InterestsReading problem in bilingual children in elementary school
-
Hitomi Hosoya, MD, PhD
Instructor, Medicine - Blood & Marrow Transplantation
BioDr. Hosoya is fellowship-trained in blood and marrow transplantation, cellular therapy and hematology with the Stanford Medicine Cancer Center and an instructor at Stanford University in the Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Her areas of expertise include transplantation, immunotherapies, and cellular therapies for patients with multiple myeloma and other plasma cell disorders. She diagnoses and treats a range of blood disorders from anemia and hemophilia to cancerous conditions like leukemia and multiple myeloma. For each patient, she prepares a personalized, comprehensive, and compassionate care plan.
Dr. Hosoya’s research is focused on improving cancer diagnostics and therapeutic decision-making in multiple myeloma. She is specifically interested in the genomics of multiple myeloma and its evolution over the course of the disease. Dr. Hosoya is studying the role of circulating tumor DNA (ctDNA) in patients with multiple myeloma and developing tools to detect and quantify tumors and their response to chemotherapy and immunotherapy, with a goal of informing personalized therapies. Dr. Hosoya demonstrated ctDNA is useful in detecting and monitoring tumor, and its prognostic value for patients undergoing CAR T-cell therapy in multiple myeloma. Her ongoing research is focused on applying cell-free DNA sequencing towards sensitive detection of copy number alterations, gene expression inferences, and understanding mechanisms of disease response and resistance in diverse therapies in multiple myeloma.
Dr. Hosoya is a member of the Society for Immunotherapy of Cancer, American Society of Clinical Oncology, American Society of Hematology, and the Japan Team Oncology Program. -
Hadi Hosseini
Associate Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsOur lab’s research portfolio crosses multiple disciplines including computational neuropsychiatry, cognitive neuroscience, multimodal neuroimaging and neurocognitive rehabilitation. Our computational neuropsychiatry research mainly involves investigating alterations in the organization of connectome in various neurodevelopmental and neurocognitive disorders using state of the art neuroimaging techniques (fMRI, sMRI, DWI, functional NIRS) combined with novel computational methods (graph theoretical and multivariate pattern analyses).
The ultimate goal of our research is to translate the findings from computational neuropsychiatry research toward developing personalized interventions. We have been developing personalized interventions that integrate computerized cognitive rehabilitation, real-time functional brain imaging and neurofeedback, as well as virtual reality (VR) tailored toward targeted rehabilitation of the affected brain networks in patients with neurocognitive disorders. -
Kristene Hossepian
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Kristene Hossepian is a licensed clinical psychologist with expertise in anxiety, depression, eating disorders, parent management training, and stress. During her doctorate training at the PGSP-Stanford Psy.D. Consortium she received extensive training in a number of evidence-based treatment approaches for children and adolescents, such as Cognitive Behavioral Therapy, Dialectical Behavioral Therapy, and Acceptance and Commitment Therapy. She completed her pre-doctoral internship at Lucile Packard Children’s Hospital/Children’s Health Council where she worked with youth struggling with severe eating disorders, chronic medical conditions, trauma, depression, and anxiety. After receiving her doctorate in 2020, Dr. Hossepian completed her postdoctoral fellowship at the Stanford University School of Medicine, where she continued to receive training in evidence-based treatments for youth with a variety of presenting problems at the inpatient and outpatient level.
Currently, Dr. Hossepian is a Clinical Assistant Professor within the Division of Child and Adolescent Psychiatry at the Stanford University School of Medicine. She works alongside Dr. Mary Sanders and Dr. Jennifer Derenne at the Comprehensive Care Program serving children and adolescents who are medically compromised due to complications with their eating disorders. Additionally, Dr. Hossepian works within Dr. Victoria Cosgrove’s Stress, Resilience, Emotion, and Mood (StREam) Laboratory to identify the ways that psychobiological stress responsivity is implicated in the emergence and propagation of affective symptomatology. Dr. Hossepian is interested in exploring the physiological mechanisms underlying mood disorders and eating disorders as well as providing children and adolescents with novel emotion regulation strategies. -
John Hotson
Professor (Clinical) of Neurology and Neurological Sciences, Emeritus
Current Research and Scholarly InterestsThe response and recovery of human visual cortex, oculomotor systems and related cognitive functions after acquired neurological disorders is a main area of interest.
-
David Hovsepian, MD
Clinical Professor, Radiology
Current Research and Scholarly InterestsI am interested in the diagnosis and treatment of vascular malformations in both children and adults; all aspects of gynecological intervention, especially uterine fibroid embolization; and in the developing sciences of quality, safety, and radiology informatics.
-
Steven K. Howard
Professor of Anesthesiology, Perioperative and Pain Medicine, Emeritus
Current Research and Scholarly InterestsOur laboratory is active in the study of human performance of medical personnel. We are actively involved in teaching health care personnel the techniques of crisis resource management (CRM) using realistic simulation. Research on sleep deprivation and fatigue and the performance of health care personnel is also an active area of study.
-
Brooke Howitt
Associate Professor of Pathology
BioDr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.
-
Michael R. Howitt
Assistant Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.
-
Dimitre Hristov
Associate Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsDevelopment and integration of X-ray, MRI and US imaging technologies for radiation therapy guidance; Design of synergistic approaches to radiation therapy delivery; Treatment planning optimization and modeling.
-
Stephanie Hsiao, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Stephanie Hsiao is a clinical assistant professor at Stanford Medicine and a full-time advanced heart failure/transplant cardiologist at the Palo Alto VA. She grew up in Taipei, Taiwan. She attended undergraduate at UC Berkeley and obtained her Master’s degree in Pharmacology at Cambridge University in the UK. She obtained her M.D. from UC San Francisco. She completed her Internal Medicine residency and General Cardiology fellowship at the California Pacific Medical Center in San Francisco, where she served as the chief resident and chief cardiology fellow. She completed her advanced heart failure/transplant cardiology fellowship at Stanford in June 2022 and joined the Stanford Faculty soon after. She has a strong interest in medical education and quality improvement. Her clinical interests include HF outreach in the VA health care systems, women’s heart health, and AHFTX fellowship curriculum design/development. Her research interests include multi-organ transplantations and advocacy of diversity-equity-inclusion in advanced HF therapies. She plans to lead a career in medical education and quality improvement to deliver exceptional and equitable care for patients needing advanced HF therapies.
-
Robert Hsieh
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioRobert W. Hsieh, M.D. Ph.D. is a medical oncologist who specializes in the treatment of prostate cancer, bladder cancer, kidney (renal) cancer and testicular cancer as a member of Stanford's multi-disciplinary Urologic Cancer Program. Dr. Hsieh obtained his M.D. and Ph.D. degrees at the University of Chicago (Pritzker School of Medicine) and subsequently came to Stanford to complete his Internal Medicine residency and Hematology and Oncology fellowship training (with a clinical focus on genitourinary cancers).
Dr. Hsieh has also had extensive experience in basic lab research (cancer stem cells, target identification and validation, pre-clinical drug discovery) having done post-doctoral work in the Clarke Lab in the Institute for Stem Cell Biology and Regenerative Medicine. He is currently involved in early phase clinical trials in immuno-oncology in industry. -
Ann Hsing
Professor (Research) of Medicine (Stanford Prevention Research Center/Cancer Institute) and of Epidemiology and Population Health
Current Research and Scholarly InterestsResearch Focus
• Epidemiology of prostate, hepatobiliary, and thyroid cancers
• Racial disparities in cancer
• Endogenous hormones/growth factors
• Circadian rhythms
• Chronic inflammation
• Genetic susceptibility
• Cancer prevention and control
• Global oncology and international studies -
Chris C.S. Hsiung
Instructor, Pathology
BioI am a molecular biologist and laboratory medicine physician. I am interested in understanding how cells turn genes on or off, and engineering ways we can turn genes on or off for biological discovery and therapeutic benefit.
In my postdoctoral work advised by Dr. Luke Gilbert (Arc Institute), I developed multiAsCas12a (multiplexed transcriptional interference Acidaminococcus Cas12a), a new functional genomics platform capable of higher-order combinatorial chromatin targeting of multiple coding and non-coding genetic elements per cell, including in pooled 6-plex CRISPRi screens. I proposed a group testing experimental framework to efficiently survey higher-order combinatorial spaces of genetic perturbations. I applied this approach to discover new enhancer elements and dissect the combinatorial logic of cis-regulatory elements. This work is available as a preprint: https://www.biorxiv.org/content/10.1101/2023.09.18.558350v2
In my prior work as an MD-PhD student co-advised by Dr. Arjun Raj and Dr. Gerd Blobel at the Univ. of Pennsylvania, I led several studies focused on how gene regulatory information is maintained or altered through mitosis in mammalian cells, using epigenomics methods, single-molecule RNA imaging, and computational analysis.
